The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain
Open accessAbstract
Purpose/Objective(s) As part of the American Association of Physicists in Medicine (AAPM) Working Group on Stereotactic Body Radiotherapy, investigating normal tissue complication probability (NTCP) after hypofractionated radiotherapy, data from published reports (PubMed indexed 1995–2018) were pooled to identify dosimetric and clinical predictors of radiation-induced brain toxicity after single-fraction stereotactic radiosurgery (SRS) or fractionated stereotactic radiosurgery (fSRS). Materials/Methods Eligible studies provided normal tissue complication probabilities (NTCPs) for the endpoints of radionecrosis, edema, or symptoms after cranial SRS/fSRS, and quantitative dose-volume metrics. Studies of patients with only glioma, meningioma, vestibular schwannoma, or brainstem targets were excluded. The data summary and analyses focused on arteriovenous malformations (AVM) and brain metastases. Results Data from 51 reports are summarized. There was wide variability in reported rates of radionecrosis. Available data for SRS/fSRS for brain metastases were more amenable to NTCP modeling than AVM data. In the setting of brain metastases, SRS/fSRS-associated RN can be difficult to differentiate from tumor progression. For single-fraction SRS to brain metastases, volumes receiving 12 Gy (V12), including the target volumes, of 5 cc, 10 cc, or >15 cc were associated with risks of symptomatic radionecrosis of approximately 10%, 15%, and 20%, respectively. SRS for AVM was associated with modestly lower rates of symptomatic radionecrosis for equivalent V12. For 3-fraction fSRS for brain metastases, normal brain tissue V18 <30 cc and V23 <7 cc were associated with <10% risk of radionecrosis. Conclusions The risk of radionecrosis after SRS and fSRS can be modeled as a function of dose and volume treated. The use of fSRS appears to reduce risks of radionecrosis for larger treatment volumes relative to SRS. More standardized dosimetric and toxicity reporting is needed to facilitate future pooled analyses that can refine predictive models of brain toxicity risks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Cox, J. D., Stetz, J., & Pajak, T. F. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00060-c · Cited by 4,792
TROTTI, A., COLEVAS, A., SETSER, A., RUSCH, V, JAQUES, D., BUDACH, V, LANGER, C., MURPHY, B., CUMBERLIN, R., & COLEMAN, C. (2003) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(03)00031-6 · Cited by 2,569
Stereotactic body radiation therapy: The report of AAPM Task Group 101
Benedict, S. H., Yenice, K. M., Followill, D., Galvin, J. M., Hinson, W., Kavanagh, B., Keall, P., Lovelock, M., Meeks, S., Papiez, L., et al. (2010) · Medical Physics · doi:10.1118/1.3438081 · Cited by 2,218
Shaw, E., Scott, C., Souhami, L., Dinapoli, R., Kline, R., Loeffler, J., & Farnan, N. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00507-6 · Cited by 1,608
Radiation Dose–Volume Effects in the Heart
Gagliardi, G., Constine, L. S., Moiseenko, V., Correa, C., Pierce, L. J., Allen, A. M., & Marks, L. B. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.04.093 · Cited by 1,227
Self-citationResponse assessment criteria for brain metastases: proposal from the RANO group
Lin, N. U., Lee, E. Q., Aoyama, H., Barani, I. J., Barboriak, D. P., Baumert, B. G., Bendszus, M., Brown, P. D., Camidge, D. R., Chang, S. M., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70057-4 · Cited by 1,088
Cited by
Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline
Gondi, V., Bauman, G., Bradfield, L., Burri, S. H., Cabrera, A. R., Cunningham, D. A., Eaton, B. R., Hattangadi‐Gluth, J. A., Kim, M. M., Kotecha, R., et al. (2022) · Practical Radiation Oncology · doi:10.1016/j.prro.2022.02.003 · Cited by 395
High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic (HyTEC): an overview
Grimm, J., Marks, L. B., Jackson, A., Kavanagh, B. D., Xue, J., & Yorke, E. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.10.039 · Cited by 153
Self-citation
Metadata
- Authors
- Milano, M. T., Grimm, J., Niemierko, A., Soltys, S. G., Moiseenko, V., Redmond, K. J., Yorke, E., Sahgal, A., Xue, J., Mahadevan, A., Muacevic, A., Marks, L. B., & Kleinberg, L. R.
- Venue
- International Journal of Radiation Oncology*Biology*Physics
- Publisher
- Elsevier BV
- Published
- 2021-05
- Volume
- 110
- Issue
- 1
- Pages
- 68-86
- ISSN
- 0360-3016 (ISSN-L)
- OpenAlex
- W3085200879
- Cited by
- 402
- References
- 71
- FWCI
- 21.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain. https://app.cochat.ai/papers/10.1016/j.ijrobp.2020.08.013
- The paper
- Milano, M. T., Grimm, J., Niemierko, A., Soltys, S. G., Moiseenko, V., Redmond, K. J., Yorke, E., Sahgal, A., Xue, J., Mahadevan, A., Muacevic, A., Marks, L. B., & Kleinberg, L. R. (2021). Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2020.08.013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.